Diabetes Clinical Trials in Detroit

Showing 21-40 of 466 trials

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

NCT05785832

A randomized controlled trial (RCT) to assess the safety and efficacy of use of Control-IQ+ technology in adults with type 2 diabetes using basal-bolus insulin therapy.

Type 2 Diabetes Treated With Insulin

Tandem Diabetes Care, Inc.319 participantsStarted Jun 2023

Newport Beach, California, United States • Atlanta, Georgia, United States • Idaho Falls, Idaho, United States +18 more locations

RECRUITINGPhase 313 miles

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

NCT05099770

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT/rilparencel injections given 12 weeks (-14 days to +28 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with T2DM and CKD.

Type 2 Diabetes MellitusChronic Kidney Diseases

Prokidney685 participantsStarted Jan 2022

Tucson, Arizona, United States • Beverly Hills, California, United States • Glendora, California, United States +83 more locations

A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Diabetes Trials in Other Cities

A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

Financial Navigation and Peer Support to Improve Diabetes Outcomes

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)

Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes

The PIVOT Trial: Project on EHR-Integrated Lifestyle Interventions for Adults Aged Fifty and Older

Teplizumab in Pediatric Stage 2 Type 1 Diabetes

A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

Closed Loop and Education for Hypoglycemia Awareness Restoration

Siplizumab in T1DM

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

Other Conditions in Detroit